4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-048431
Chairman and CEO bought 3,400 shares at an average $1.47 ($5,004)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-07-26 | Purchase | +500 | $1.50 | $750 | 10,803,471 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-27 | Purchase | +500 | $1.50 | $750 | 10,803,971 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-28 | Purchase | +2,400 | $1.46 | $3,504 | 10,806,371 | D |
| Open-market purchases · 3,400 sh · avg $1.47 · $5,004 | |||||||
Loading xslF345X03/doc4.xml…